Loading data
RVSNNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.49 m USD | 1.3 m USD | 142 k USD | 421 k USD | 888 k USD |
| Cost of revenue | 935 k USD | 850 k USD | 61 k USD | 661 k USD | 657 k USD |
| Gross profit | 552 k USD | 450 k USD | 81 k USD | -240 k USD | 231 k USD |
| Research and development expense | 6.86 m USD | 5.28 m USD | 7.15 m USD | 6.23 m USD | 7.21 m USD |
| Selling, general and administrative expense | — | — | — | 4.27 m USD | 3.32 m USD |
| Operating profit | -11.74 m USD | -9 m USD | -11.4 m USD | -10.74 m USD | -10.29 m USD |
| Net income (reported basis) | -11.1 m USD | -30.71 m USD | -11.15 m USD | -10.48 m USD | -10.22 m USD |
| Basic earnings per share | -6.15 USD/share | -55.41 USD/share | -129.26 USD/share | -5.91 USD/share | -8.94 USD/share |
| Diluted earnings per share | -6.15 USD/share | -55.41 USD/share | -129.26 USD/share | -5.91 USD/share | -8.94 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.